COLESTID

This brand name is authorized in United States. It is also authorized in Canada, Estonia, Israel, New Zealand, Spain, UK.

Active ingredients

The drug COLESTID contains one active pharmaceutical ingredient (API):

1	Colestipol UNII X7D10K905G - COLESTIPOL HYDROCHLORIDE
	Colestipol is an ion exchange resin which lowers plasma cholesterol through binding with bile acids in the intestinal lumen. It is indicated as adjunctive therapy to diet in the management of patients with elevated cholesterol levels who have not responded adequately to diet.
	Read more about Colestipol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COLESTID Granule for oral suspension	MPI, US: SPL/Old	FDA, National Drug Code (US)
COLESTID Tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)
COLESTID Granule for oral suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AC02	Colestipol	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AC Bile acid sequestrants
Discover more medicines within C10AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00642975, 02132680
EE	Ravimiamet	1827042
ES	Centro de información online de medicamentos de la AEMPS	55596
GB	Medicines & Healthcare Products Regulatory Agency	40831, 40838
IL	מִשְׂרַד הַבְּרִיאוּת	29
NZ	Medicines and Medical Devices Safety Authority	2289
US	FDA, National Drug Code	0009-0260, 0009-0370, 0009-0450